Cetyl Myristoleate

Supplements · Joint Health · Supplement, Typed Supps

A fatty compound first noticed in mice that seemed naturally protected from arthritis, now sold as a joint supplement — though the human evidence backing it up is still thin.

Stage by stage

Intake (Capsule or topical cream): Absorbed through the gut or skin depending on form.
Small intestine / skin (Absorbed): Enters systemic circulation.
Bloodstream (Circulates): Carried through the blood to tissues throughout the body.
Joint tissue (Cartilage and synovial tissue): Proposed anti-inflammatory and lubricating action, based mainly on animal research and a small number of human trials.

What the evidence supports

Reducing pain and improving function in osteoarthritis or other joint conditions — limited evidence. A handful of small, mostly older human trials, including a widely cited 1997 multicenter trial and a more recent minimal-effective-dose trial, reported reduced joint pain scores versus placebo. But the overall human trial base is small, several key studies are old, industry-linked, or not independently replicated, and this falls short of strong evidence.
Protecting against arthritis based on animal model research — limited evidence. The original discovery and much of the mechanistic support comes from studies in mice and rats showing protection against experimentally induced arthritis. This preclinical signal is real but doesn’t by itself establish a clinical effect in people.
Superiority over standard osteoarthritis treatments like NSAIDs or glucosamine — insufficient evidence. There isn’t quality head-to-head trial evidence comparing cetyl myristoleate against established osteoarthritis treatments, so claims of superiority or equivalence aren’t supported.

Typical dose

Oral doses in trials have ranged widely, from a few hundred milligrams up to several grams per day, alongside topical cream formulations

Upper limit: No established UL

Timing

Dosing varies widely by formulation; no single regimen is firmly established as optimal.

Time to effect

Several weeks: The small existing trials generally measured pain changes over several weeks of use.

Common myth

"Cetyl myristoleate is a scientifically proven arthritis cure." In reality: Its discovery story in arthritis-resistant mice is real, but the human clinical trial base since then remains small and dated, supporting only limited, not strong, evidence for joint pain claims.